Short Interest in Hypermarcas (OTCMKTS:HYPMY) Declines By 99.9%

Hypermarcas (OTCMKTS:HYPMY) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 16 shares, a decline of 99.9% from the November 30th total of 11,176 shares. Based on an average trading volume of 13,330 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold. Approximately 0.0% of the shares of the company are short sold. Based on an average trading volume of 13,330 shares, the days-to-cover ratio is currently 0.0 days.

Hypermarcas Price Performance

OTCMKTS:HYPMY traded up $0.28 during midday trading on Wednesday, hitting $4.41. 1,437 shares of the stock were exchanged, compared to its average volume of 22,069. The company has a market capitalization of $2.79 billion, a price-to-earnings ratio of 19.15 and a beta of 0.73. The company has a current ratio of 1.27, a quick ratio of 0.84 and a debt-to-equity ratio of 0.61. Hypermarcas has a one year low of $2.86 and a one year high of $5.18. The business has a 50-day moving average price of $4.53 and a two-hundred day moving average price of $4.51.

Hypermarcas (OTCMKTS:HYPMY) last issued its quarterly earnings results on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 6.89% and a net margin of 12.03%.The company had revenue of $408.83 million for the quarter.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.